ライフサイエンスコーパス: stereotactic radiosurgery

1 melanoma; the surgical bed was treated with stereotactic radiosurgery.

2 clude surgery, whole-brain radiotherapy, and stereotactic radiosurgery.

3 find significant associations in studies of stereotactic radiosurgery.

4 otherapy (WBRT), with or without surgery, or stereotactic radiosurgery.

5 n radiation therapy, surgical resection, and stereotactic radiosurgery.

6 including conventional radiation as well as stereotactic radiosurgery.

7 66 (90%) of 73 metastases at 20 weeks after stereotactic radiosurgery; 61% maintained local control

8 ities, particularly image-guided surgery and stereotactic radiosurgery, allows clinicians who are foc

9 lar embolization, neurosurgical excision, or stereotactic radiosurgery alone or in combination).

10 TOG institutions--167 were assigned WBRT and stereotactic radiosurgery and 164 were allocated WBRT al

11 roversial and can include surgical excision, stereotactic radiosurgery and embolization.

12 either (125)I interstitial brachy-therapy or stereotactic radiosurgery and is associated with a signi

13 adiation therapy (WBRT), surgical resection, stereotactic radiosurgery, and chemotherapy.

14 iew is focused on indications for resection, stereotactic radiosurgery, and fractionated radiotherapy

15 The new brain lesion was treated with stereotactic radiosurgery, and he began systemic therapy

16 hree-dimensional treatment planning systems, stereotactic radiosurgery, and intensity modulated radia

17 ion of endovascular embolisation techniques, stereotactic radiosurgery, and microsurgery, allowing ef

18 brain radiation therapy, surgical resection, stereotactic radiosurgery, and systemic therapy.

19 d therapy, such as whole-brain radiotherapy, stereotactic radiosurgery, and/or surgical resection.

20 rmations (CCMs) by neurosurgical excision or stereotactic radiosurgery are imprecise and vary between

21 Long-term effects, especially important for stereotactic radiosurgery, are unknown.

22 radiation therapy (WBRT) or WBRT followed by stereotactic radiosurgery boost.

23 The use stereotactic radiosurgery for brain metastases has expan

24 paper will review the recent publications of stereotactic radiosurgery for brain tumors.

25 proach towards predicting the outcomes after stereotactic radiosurgery for cerebral arteriovenous mal

26 Finally, as radiation therapy and stereotactic radiosurgery for pituitary tumors gains mor

27 ere was a survival advantage in the WBRT and stereotactic radiosurgery group for patients with a sing

28 Recently, stereotactic radiosurgery has emerged as an increasingly

29 Despite its controversial beginning, stereotactic radiosurgery has rapidly gained acceptance

30 Recent publications of stereotactic radiosurgery have increased our understandi

31 tumor is considered radiotherapy resistant, stereotactic radiosurgery is recommended; if the BMs are

32 Stereotactic radiosurgery is the principal alternative t

33 Stereotactic radiosurgery may offer a survival advantage

34 3.3 years) and 5.4 (95% CI 4.5 to 6.4) after stereotactic radiosurgery (median follow-up 4.1 years).

35 s, three received 13.5-18-Gy single-fraction stereotactic radiosurgery; one received 19.8 Gy in three

36 ic edema were a large tumor, single-fraction stereotactic radiosurgery, or use of more than 6 Gy per

37 We aimed to assess whether stereotactic radiosurgery provided any therapeutic benef

38 leveraging the capabilities of image-guided stereotactic radiosurgery, separation surgery, vertebrop

39 WBRT and stereotactic radiosurgery should, therefore, be standard

40 ergo whole brain radiation therapy (WBRT) or stereotactic radiosurgery (SRS) delivered only to the ra

41 ding whole-brain radiation therapy (WBRT) to stereotactic radiosurgery (SRS) for the control of brain

42 he authors to explore the use of Gamma Knife stereotactic radiosurgery (SRS) for this common problem.

43 s and retrospective series, neurosurgery and stereotactic radiosurgery (SRS) may prolong survival in

44 We did this study to determine if stereotactic radiosurgery (SRS) to the surgical cavity i

45 However, stereotactic radiosurgery (SRS) to the surgical cavity i

46 The concept of stereotactic radiosurgery (SRS) was first described by L

47 ntroversial and includes surgical resection, stereotactic radiosurgery (SRS), and whole-brain radiati

48 Purpose Stereotactic radiosurgery (SRS), whole-brain radiotherap

49 ly improves tumor control in the brain after stereotactic radiosurgery (SRS), yet because of its asso

50 patients received radiotherapy to the brain (stereotactic radiosurgery [SRS] or whole-brain radiother

51 paradigms has been the integration of spinal stereotactic radiosurgery (SSRS), allowing delivery of t

52 htly more prolonged course of WBRT, surgery, stereotactic radiosurgery, systemic therapy, or a combin

53 ion and influence treatment in patients with stereotactic radiosurgery-treated metastases.

54 apy (SBRT) is derived from the techniques of stereotactic radiosurgery used to treat lesions in the b

55 The median survival time after stereotactic radiosurgery was 53 weeks and correlated wi

56 Rates of response to stereotactic radiosurgery were calculated.